| IFN-α kinoid in systemic lupus erythematosus: Results from a phase IIb, randomised, placebo-controlled study |
| Houssiau Frederic A.12, Thanou Aikaterini3, Mazur Minodora4, Ramiterre Edgar B.5, Gomez Mora Danny Alexis6, Misterska-Skora Maria Magdalena7, Perich-Campos Risto Alfredo8, Smakotina Svetlana9, Cerpa Cruz Sergio10, Louzir Bassem11, Croughs Therese12, Tee Michael Lucas13 |
2 Saint-Luc University Clinics, Brussels,
3 Oklahoma Medical Research Foundation, Oklahoma City,
4 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
5 Southern Philippines Medical Center, Davao,
7 Medical Center Oporow, Wrocław,
8 Guillermo Almenara Irigoyen National Hospital, Lima,
9 Kemerovo State Medical University,
10 Hospital Civil de Guadalajara 'Fray Antonio Alcalde', Guadalajara,
11 Military Hospital of Tunis,
12 Neovacs S.A, Paris,
13 University of the Philippines Manila |
| Annals of the Rheumatic Diseases |
| Nr. / 2019 / ISSN - /ISSNe 0003-4967 |
| Disponibil online 13 March, 2023. Descarcări-0. Vizualizări-216 |
----------------------------------------------------------------------------------------------------------------------------------- | Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: A phase II dose-ranging randomised controlled trial |
| Wallace Daniel J.1, Strand Vibeke2, Merrill Joan T.3, Popa Serghei4, Spindler Alberto J.5, Eimon Aliciaf6, Noi Autori |
1 Cedars-Sinai Medical Center, Los Angeles,
2 Stanford University, Palo Alto,
3 Oklahoma Medical Research Foundation, Oklahoma City,
4 Timofei Moșneaga Republican Clinical Hospital,
5 Private Medical Center of Rheumatology, Tucuman,
6 CEMIC, Buenos Aires |
| Annals of the Rheumatic Diseases |
| Nr. / 2017 / ISSN - /ISSNe 0003-4967 |
| Disponibil online 10 June, 2022. Descarcări-0. Vizualizări-239 |
----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------
1-20 of 25
